Should carbohydrate-modified diets be the first option for weight loss in people with impaired glucose metabolism? A scoping review.
Katie M EllisonHolly R WyattJames O HillR Drew SayerPublished in: Obesity reviews : an official journal of the International Association for the Study of Obesity (2024)
While the "precision nutrition" movement is at an early stage of development, several investigations have compared low-fat versus carbohydrate (CHO)-modified diets (i.e., low-or-reduced-CHO, low glycemic index/load diets, and high-fiber) in people with normal versus impaired glucose metabolism. The purpose of this scoping review was to summarize evidence in support of the hypothesis that CHO-modified diets are more effective for weight loss among people with impaired glucose metabolism. Fifteen articles were included in this review: seven retrospective analyses of randomized clinical trials and eight prospective randomized clinical trials with prespecified hypotheses related to a diet (low-fat vs. CHO-modified) × phenotype (normal vs. impaired) interaction. Evidence in support of the hypothesis was identified in six of seven retrospective and three of eight prospective studies, which led to a recommendation of CHO-modified diets as a first-line option for people with impaired glucose metabolism. However, the evidence in support of this recommendation is relatively weak, and dietary prescriptions should consider additional contextual information that may influence overall dietary adherence. Additional and rigorous research using innovative randomized experimental approaches is needed for stronger dietary weight loss recommendations based on pretreatment glycemic status.
Keyphrases
- weight loss
- bariatric surgery
- roux en y gastric bypass
- glycemic control
- gastric bypass
- early stage
- type diabetes
- adipose tissue
- double blind
- weight gain
- physical activity
- obese patients
- cross sectional
- randomized controlled trial
- body mass index
- healthcare
- clinical trial
- fatty acid
- insulin resistance
- placebo controlled
- study protocol
- metabolic syndrome
- health information
- rectal cancer